Very surprised to see ARQ was not discussed. Maquarie is very positive apparently. I understand Macquarie liked that the cash flow was up and that the target price is approx 1.60 ish.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025
Week 48 Wrap: ASX flirts with 8,500pts; APRA declines mortgage loan easing; Trump's Bessent tied to Dem donor
